Physician profile
David C Langley
NPI 1447236690
$7,352.25
in general payments reported to CMS, 2019-2025
22 companies · $946 in 2025
The $946 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,675 · 2020: $256 · 2021: $529 · 2022: $391 · 2023: $941 · 2024: $615 · 2025: $946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,502.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $1,861.69 | 2019 | |
| Endologix LLC | $1,540.14 | 2019-2025 | Alto Abdominal Stent Graft System, Endocross Device, Torus Stent Graft System |
| Siemens Medical Solutions USA, INC. | $894.81 | 2019 | |
| Silk Road Medical, INC. | $688.11 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| W. L. Gore & Associates, INC. | $649.41 | 2019-2023 | Gore Tag Thoracic Endoprosthesis |
| Boston Scientific Corporation | $384.68 | 2019-2025 | Athletis, Ranger, Enroute Transcarotid Stent |
| Janssen Pharmaceuticals, INC | $285.91 | 2019-2023 | Xarelto |
| Medtronic, INC. | $148.91 | 2024 | Abre, Ellipsys Vascular Access System, Ligasure |
| Cvrx, INC. | $134.84 | 2022 | |
| Smith+Nephew, INC. | $102.56 | 2021-2025 | Stravix, Oasis |
| Tactile Systems Technology INC | $91.92 | 2019-2021 | |
| Inari Medical, INC. | $89.19 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $88.34 | 2023 | Dragonfly Opstar |
| Penumbra, INC. | $87.14 | 2025 | Penumbra System |
| Intuitive Surgical, INC. | $70.53 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $66.01 | 2019-2024 | Ethicon, Echelon; Endopath, Evarrest |
| Vertex Pharmaceuticals Incorporated | $42.03 | 2025 | |
| Becton, Dickinson and Company | $34.00 | 2025 | Rotarexs 6 F X 135 Cm |
| Medtronic Vascular, INC. | $31.36 | 2019 | |
| Baudax Bio INC. | $21.91 | 2021 | |
| Bard Peripheral Vascular, INC. | $19.66 | 2019 | |
| Pfizer INC. | $19.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Langley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.